CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 11 filers reported holding CITIUS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $29 | -6.5% | 23,846 | -38.9% | 0.00% | -50.0% |
| Q4 2022 | $31 | -100.0% | 39,005 | -52.1% | 0.00% | -33.3% |
| Q2 2022 | $75,000 | +8.7% | 81,410 | +313.0% | 0.01% | -14.3% |
| Q2 2021 | $69,000 | -54.3% | 19,713 | -86.7% | 0.01% | -56.2% |
| Q4 2020 | $151,000 | +26.9% | 147,663 | +29.3% | 0.02% | -20.0% |
| Q3 2020 | $119,000 | +14.4% | 114,223 | +24.4% | 0.02% | +66.7% |
| Q2 2020 | $104,000 | +700.0% | 91,793 | +455.7% | 0.01% | +1100.0% |
| Q3 2019 | $13,000 | – | 16,519 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GSA CAPITAL PARTNERS LLP | 498,783 | $394 | 0.05% |
| Inspire Advisors, LLC | 195,946 | $154,797 | 0.04% |
| Wealth Advisory Solutions, LLC | 155,850 | $123,122 | 0.03% |
| Miller Investment Management, LP | 50,000 | $39,500 | 0.01% |
| Virtu Financial LLC | 39,005 | $31 | 0.00% |
| Pasadena Private Wealth, LLC | 10,965 | $8,662 | 0.00% |
| Jump Financial, LLC | 49,251 | $38,908 | 0.00% |
| Csenge Advisory Group | 15,000 | $11,850 | 0.00% |
| Qube Research & Technologies Ltd | 120,580 | $95,258 | 0.00% |
| Syverson Strege & Co | 2,145 | $1,695 | 0.00% |